Clinical Trial Update: Artificial Intelligence to Measure Adherence to Oral Medication [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the use of artificial intelligence to measure adherence to oral medications in individuals with first-episode psychosis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• First Episode Psychosis

Snippet

Sponsor: Northwell Health | Conditions: First Episode Psychosis | Phase 4 | Status: RECRUITING